U.S., Dec. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07297173) titled 'Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia' on Dec. 09.
Brief Summary: This is a Phase 1 clinical study designed to evaluate the safety, tolerability, and preliminary efficacy of chemotherapy combining with HLA-mismatched G-CSF mobilized peripheral blood mononuclear cell (GPBMC) infusion as a bridging therapy to allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with relapsed and refractory (R/R) leukemia.
Study Start Date: Dec. 01
Study Type: INTERVENTIONAL
Condition:
Relapsed Leukemia
Refractory Leukemia
Intervention:
PROCEDURE: Chemotherapy...